Showing results (1011-1020 of 5,597) with videos related to
Sort By:
Pageof 560
Journal of Cancer|September 21, 2017
IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic TumoursLuyan Mu, Wanzhen Xu, Qingla Li, et al.Journal of Cancer|September 21, 2017
Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling PathwayDong-Dong Cheng, Bin Zhu, Shi-Jie Li, et al.Journal of Cancer|September 21, 2017
Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung CancerLei Cong, Zhi-Yong Qiu, Yang Zhao, et al.Journal of Cancer|September 21, 2017
Villi-specific Gene Expression Reveals Novel Prognostic Biomarkers in Multiple Human CancersBotao Zhang, Lin Feng, Honglin Guo, et al.Journal of Cancer|September 21, 2017
HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter ProteinsLei Sun, Jia Ke, Zhen He, et al.Journal of Cancer|September 21, 2017
The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal CancerSeung Tae Kim, Su-Jin Lee, Jeeyun Lee, et al.Journal of Cancer|September 21, 2017
Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 casesXiaomin Ou, Tingting Xu, Xiayun He, et al.Journal of Cancer|September 21, 2017
Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed PhenotypeCinthya Gurrion, Maritere Uriostegui, Mario ZuritaJournal of Cancer|September 21, 2017
Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC)Jung Kwon Kim, Kyung Chul Moon, Chang Wook Jeong, et al.Journal of Cancer|September 21, 2017
In Surgical Colon Cancer Patients Extended-Duration Thromboprophylaxis (30 days) with the Highest Dose of Tinzaparin (4,500 IU s.c./q.d.) Normalizes the Postoperative VEGF LevelsMichail Mitsis, Panagiotis Koliou, Christina Bali, et al.Pageof 560